• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加德西(Gardasil)热稳定性评估。

Evaluation of the thermal stability of Gardasil.

作者信息

Shank-Retzlaff Mary L, Zhao Qinjian, Anderson Carrie, Hamm Melissa, High Katrina, Nguyen Mai, Wang Feng, Wang Ning, Wang Bei, Wang Yang, Washabaugh Michael, Sitrin Robert, Shi Li

机构信息

Merck Research Laboratories Department of Bioprocess, West Point, Pennsylvania, USA.

出版信息

Hum Vaccin. 2006 Jul-Aug;2(4):147-54. doi: 10.4161/hv.2.4.2989. Epub 2006 Jul 4.

DOI:10.4161/hv.2.4.2989
PMID:17012891
Abstract

The thermostability of GARDASIL (Merck & Co., Inc, Whitehouse Station, NJ, USA), a developmental vaccine against human papillomavirus (HPV), was evaluated using an enzyme immunoassay, referred to as the in vitro relative potency (IVRP) assay and differential scanning calorimetry (DSC). Gardasil samples were stored at temperatures ranging from 4 to 42 degrees C and tested for IVRP at various time points. Extrapolation of the IVRP results indicates GARDASIL is extremely stable. The half-life of the vaccine is estimated to be 130 months or longer at temperatures up to 25 degrees C. At 37 degrees C, the half-life is predicted to be 18 months and at 42 degrees C, the half-life is predicted to be approximately three months. Differential scanning calorimetry (DSC) analysis was used to evaluate the process of protein denaturation during a rapid temperature increase (as opposed to long-term storage at a specific temperature). Differences were seen among the DSC profiles of the four HPV types tested. This indicates that small differences in the amino acid structure can have a significant effect on the intermolecular contacts that stabilize the L1 proteins and the VLP assembly. For the Gardasil samples evaluated here, DSC results demonstrated the relative overall structural stability of the VLPs, but were not predictive of the excellent long-term stability observed with the IVRP assay.

摘要

利用一种酶免疫测定法(即体外相对效价(IVRP)测定法)和差示扫描量热法(DSC),对一种处于研发阶段的抗人乳头瘤病毒(HPV)疫苗佳达修(美国新泽西州怀特豪斯站默克公司生产)的热稳定性进行了评估。将佳达修样品储存在4至42摄氏度的温度范围内,并在不同时间点进行IVRP测试。IVRP结果的外推表明佳达修极其稳定。在高达25摄氏度的温度下,该疫苗的半衰期估计为130个月或更长。在37摄氏度时,半衰期预计为18个月,在42摄氏度时,半衰期预计约为三个月。差示扫描量热法(DSC)分析用于评估在温度快速升高过程中(与在特定温度下长期储存相反)蛋白质变性的过程。在所测试的四种HPV类型的DSC图谱中观察到了差异。这表明氨基酸结构上的微小差异会对稳定L1蛋白和病毒样颗粒(VLP)组装的分子间接触产生重大影响。对于此处评估的佳达修样品,DSC结果证明了VLP相对整体的结构稳定性,但无法预测IVRP测定法所观察到的出色的长期稳定性。

相似文献

1
Evaluation of the thermal stability of Gardasil.加德西(Gardasil)热稳定性评估。
Hum Vaccin. 2006 Jul-Aug;2(4):147-54. doi: 10.4161/hv.2.4.2989. Epub 2006 Jul 4.
2
Correlation between mouse potency and in vitro relative potency for human papillomavirus Type 16 virus-like particles and Gardasil vaccine samples.16型人乳头瘤病毒样颗粒和加德西疫苗样品的小鼠效力与体外相对效力之间的相关性
Hum Vaccin. 2005 Sep-Oct;1(5):191-7. doi: 10.4161/hv.1.5.2126. Epub 2005 Sep 20.
3
Cervarix, the GSK HPV-16/HPV-18 AS04-adjuvanted cervical cancer vaccine, demonstrates stability upon long-term storage and under simulated cold chain break conditions.卉妍康(Cervarix),葛兰素史克公司生产的人乳头瘤病毒16型/人乳头瘤病毒18型AS04佐剂宫颈癌疫苗,在长期储存和模拟冷链中断条件下均表现出稳定性。
Hum Vaccin. 2009 Jul;5(7):467-74. doi: 10.4161/hv.8485. Epub 2009 Jul 19.
4
The humoral response to Gardasil over four years as defined by total IgG and competitive Luminex immunoassay.通过总IgG和竞争性Luminex免疫测定法定义的四年内对加德西疫苗的体液免疫反应。
Hum Vaccin. 2011 Feb;7(2):230-8. doi: 10.4161/hv.7.2.13948. Epub 2011 Feb 1.
5
Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirions.接种加德西疫苗的女性体内产生的抗体可交叉中和人乳头瘤病毒45型假病毒。
Hum Vaccin. 2007 Jul-Aug;3(4):109-15. doi: 10.4161/hv.3.4.4058. Epub 2007 Feb 24.
6
A novel candidate HPV vaccine: MS2 phage VLP displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9.一种新型 HPV 候选疫苗:展示串联 HPV L2 肽的 MS2 噬菌体 VLPs 为小鼠提供了与佳达修 9 相似的保护效果。
Antiviral Res. 2017 Nov;147:116-123. doi: 10.1016/j.antiviral.2017.09.012. Epub 2017 Sep 20.
7
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis.两种人乳头瘤病毒疫苗的交叉保护效力:系统评价和荟萃分析。
Lancet Infect Dis. 2012 Oct;12(10):781-9. doi: 10.1016/S1473-3099(12)70187-1. Epub 2012 Aug 22.
8
Second-generation prophylactic HPV vaccines: current options and future strategies for vaccines development.第二代预防性人乳头瘤病毒疫苗:疫苗研发的当前选择和未来策略
Minerva Med. 2016 Feb;107(1):26-38. Epub 2015 Oct 16.
9
Evolution of type-specific immunoassays to evaluate the functional immune response to Gardasil: a vaccine for human papillomavirus types 16, 18, 6 and 11.评估针对加德西(一种针对人乳头瘤病毒16、18、6和11型的疫苗)的功能性免疫反应的型特异性免疫测定法的演变
Hum Vaccin. 2008 Mar-Apr;4(2):134-42. doi: 10.4161/hv.4.2.5261. Epub 2007 Nov 4.
10
Prophylactic immunization with human papillomavirus vaccines induces oral immunity in mice.用人乳头瘤病毒疫苗进行预防性免疫可在小鼠中诱导口腔免疫。
Laryngoscope. 2018 Jan;128(1):E16-E20. doi: 10.1002/lary.26772. Epub 2017 Sep 4.

引用本文的文献

1
Overcoming dengue vaccine challenges through next-generation virus-like particle immunization strategies.通过下一代病毒样颗粒免疫策略克服登革热疫苗挑战。
Front Cell Infect Microbiol. 2025 Jun 16;15:1614805. doi: 10.3389/fcimb.2025.1614805. eCollection 2025.
2
Trends in uptake and impact of thermostable vaccines in Africa.非洲耐热疫苗的接种趋势及其影响
Ther Adv Vaccines Immunother. 2025 Jun 18;13:25151355251341662. doi: 10.1177/25151355251341662. eCollection 2025.
3
Bayesian hierarchical model predicts biopharmaceutical stability indicators and shelf life with application to multivalent human papillomavirus vaccine.
贝叶斯分层模型预测生物制药稳定性指标和保质期,并应用于多价人乳头瘤病毒疫苗。
Sci Rep. 2025 May 19;15(1):17333. doi: 10.1038/s41598-025-99458-y.
4
Chimeric Human Papillomavirus-16 Virus-like Particles Presenting HIV-1 P18I10 Peptide: Expression, Purification, Bio-Physical Properties and Immunogenicity in BALB/c Mice.嵌合型人乳头瘤病毒 16 病毒样颗粒展示 HIV-1 P18I10 肽:在 BALB/c 小鼠中的表达、纯化、生物物理特性和免疫原性。
Int J Mol Sci. 2023 Apr 29;24(9):8060. doi: 10.3390/ijms24098060.
5
Chimeric Human Papillomavirus-16 Virus-like Particles Presenting P18I10 and T20 Peptides from HIV-1 Envelope Induce HPV16 and HIV-1-Specific Humoral and T Cell-Mediated Immunity in BALB/c Mice.呈现来自HIV-1包膜的P18I10和T20肽的嵌合人乳头瘤病毒16型病毒样颗粒在BALB/c小鼠中诱导HPV16和HIV-1特异性体液免疫和T细胞介导的免疫。
Vaccines (Basel). 2022 Dec 21;11(1):15. doi: 10.3390/vaccines11010015.
6
Novel Vaccine Strategies and Factors to Consider in Addressing Health Disparities of HPV Infection and Cervical Cancer Development among Native American Women.新型疫苗策略及解决美国原住民妇女 HPV 感染和宫颈癌发展方面健康差异需考虑的因素。
Med Sci (Basel). 2022 Sep 13;10(3):52. doi: 10.3390/medsci10030052.
7
Development of functionally relevant potency assays for monovalent and multivalent vaccines delivered by evolving technologies.通过不断发展的技术递送的单价和多价疫苗的功能相关效力测定方法的开发。
NPJ Vaccines. 2022 May 5;7(1):50. doi: 10.1038/s41541-022-00470-4.
8
Methylparaben as a preservative in the development of a multi-dose HPV-2 vaccine.尼泊金甲酯作为多剂量 HPV-2 疫苗开发中的防腐剂。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2067421. doi: 10.1080/21645515.2022.2067421. Epub 2022 Apr 26.
9
Polysorbate 80 and histidine quantitative analysis by NMR in the presence of virus-like particles.聚山梨酯 80 和组氨酸的定量分析 NMR 在病毒样颗粒的存在下。
Electrophoresis. 2022 Jul;43(13-14):1408-1414. doi: 10.1002/elps.202100189. Epub 2022 Apr 26.
10
Biophysical Characterization of Viral and Lipid-Based Vectors for Vaccines and Therapeutics with Light Scattering and Calorimetric Techniques.利用光散射和量热技术对用于疫苗和治疗的病毒载体和脂质载体进行生物物理表征。
Vaccines (Basel). 2021 Dec 30;10(1):49. doi: 10.3390/vaccines10010049.